AMGEN ANNOUNCES WEBCAST OF 2024 THIRD QUARTER FINANCIAL RESULTS
Amgen (NASDAQ:AMGN) has scheduled its third quarter 2024 financial results announcement for Wednesday, October 30, 2024, after U.S. market close. The company will host a conference call at 4:30 p.m. ET featuring Chairman and CEO Robert A. Bradway and senior management. The call will be webcast live and accessible to investors, media, and the public through Amgen's website. The webcast recording will remain available for replay for at least 90 days post-event.
Amgen (NASDAQ:AMGN) ha programmato l'annuncio dei risultati finanziari del terzo trimestre 2024 per mercoledì 30 ottobre 2024, dopo la chiusura del mercato statunitense. La società ospiterà una conference call alle 16:30 ET con il Presidente e CEO Robert A. Bradway e la direzione senior. La chiamata sarà trasmessa in diretta in streaming e sarà accessibile a investitori, media e pubblico tramite il sito web di Amgen. La registrazione della trasmissione rimarrà disponibile per la visione per almeno 90 giorni dopo l'evento.
Amgen (NASDAQ:AMGN) ha programado el anuncio de sus resultados financieros del tercer trimestre de 2024 para el miércoles 30 de octubre de 2024, después del cierre del mercado estadounidense. La compañía llevará a cabo una conferencia telefónica a las 4:30 p.m. ET con el Presidente y CEO Robert A. Bradway y la alta dirección. La llamada se transmitirá en vivo y será accesible para inversores, medios de comunicación y el público a través del sitio web de Amgen. La grabación de la transmisión estará disponible para reproducción durante al menos 90 días después del evento.
암젠 (NASDAQ:AMGN)은 2024년 3분기 재무 결과 발표를 2024년 10월 30일 수요일, 미국 시장 마감 후에 할 예정입니다. 회사는 로버트 A.브래드웨이 회장 겸 CEO와 고위 경영진이 참여하는 컨퍼런스 콜을 오후 4시 30분(ET)에 진행할 것입니다. 이 통화는 실시간으로 웹 캐스트되며, 투자자, 언론 및 일반 대중이 암젠의 웹사이트를 통해 접근할 수 있습니다. 웹 캐스트 기록은 이벤트 후 최소 90일 동안 재생할 수 있도록 제공됩니다.
Amgen (NASDAQ:AMGN) a prévu d'annoncer ses résultats financiers pour le troisième trimestre 2024 le mercredi 30 octobre 2024, après la fermeture des marchés aux États-Unis. La société organisera une conférence téléphonique à 16h30 ET, avec le Président et CEO Robert A. Bradway et la haute direction. L'appel sera diffusé en direct et accessible aux investisseurs, aux médias et au public via le site Web d'Amgen. L'enregistrement du webcast restera disponible pour être visionné pendant au moins 90 jours après l'événement.
Amgen (NASDAQ:AMGN) hat die Bekanntgabe seiner finanziellen Ergebnisse für das dritte Quartal 2024 für Mittwoch, den 30. Oktober 2024, nach Börsenschluss in den USA angesetzt. Das Unternehmen wird um 16:30 Uhr ET eine Telefonkonferenz ausrichten, an der Vorsitzender und CEO Robert A. Bradway sowie das obere Management teilnehmen werden. Der Anruf wird live übertragen und ist für Investoren, Medien und die Öffentlichkeit über die Website von Amgen zugänglich. Die Aufnahme des Webcasts wird mindestens 90 Tage nach der Veranstaltung zur Verfügung stehen.
- None.
- None.
Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and the general public.
The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.
About Amgen
Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.
In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.
For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, TikTok, YouTube and Threads.
CONTACT: Amgen,
Elissa Snook, 609-251-1407 (media)
Justin Claeys, 805-313-9775 (investors)
View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-announces-webcast-of-2024-third-quarter-financial-results-302285159.html
SOURCE Amgen
FAQ
When will Amgen (AMGN) release Q3 2024 earnings?
What time is Amgen's (AMGN) Q3 2024 earnings call?
How can I access Amgen's (AMGN) Q3 2024 earnings call?
How long will Amgen's (AMGN) Q3 2024 earnings call replay be available?
